Altimmune (ALT), University of Alabama at Birmingham Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID
Go back to Altimmune (ALT), University of Alabama at Birmingham Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID| iShares Diversified Alternatives Trust (NASDAQ: ALT) | Delayed: 3.36 -0.06 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.42 | 52 Week High | $54.24 | |||
| Open | $3.46 | 52 Week Low | $48.35 | |||
| Day High | $3.55 | P/E | N/A | |||
| Day Low | $3.34 | EPS | $0.00 | |||
| Volume | 3,590,743 | |||||
